BioInvent International (STO:BINV)46% objective response rate (6 of 13 evaluable patients) and a 92% disease control rate (12 of 13) in relapsed/refractory CTCLImmune activation confirmed by CD8+ T ...

A pair of teenagers have launched a new tech company aimed at helping family-run and small businesses create professional ...

Blue Origin showed off a device that it claims can store energy from hot Moon dust inside a battery. We have questions.

CHANTILLY, Va., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that Carey Smith, chair, president, and chief executive officer will participate in a fireside chat ...

All three dose groups (50 mg, 100 mg and 200 mg) showed impressive monotherapy efficacy, with VGPR+ (very good partial response or better) of ≥70% despite limited follow-up; evidence shows that these ...

Q3 2025 Earnings Call Transcript December 5, 2025 Operator: Welcome to the Beta Technologies Third Quarter 2025 Earnings Conference Call. [Operator Instructions] I will now turn the call over to Devon ...

B-cell lymphoma in the 3L+ setting 83% overall response and 61% complete response rates in cohort comprised predominantly of patients with primary refractory large B-cell lymphoma in the 2L setting ...

Erie bought the $6.9 million land north of town center in 2023 with a vision for open space and mixed-income housing. Two ...

The struggle we have is when you put all of them together, they ultimately act as prohibitive to the development of the ...

ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and Nova Minerals Limited (Nasdaq:NVA) on the ...

Poster outlines clinical benefit with acceptable safety profile across 9 tested dosing regimensAccelerated step-up dosing and higher dosing ...

Erbil Governor Omed Khoshnaw confirmed two deaths in the Lanaz refinery riots, rejected land seizure claims, and vowed legal ...